ARTICLE | Clinical News
RXI-109: Completed Phase IIa enrollment
January 5, 2015 8:00 AM UTC
RXi completed enrollment in the double-blind Phase IIa RXI-109-1301 trial of intradermal RXI-109 in about 32 patients with a long hypertrophic scar in the lower abdominal area undergoing scar revision...